Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 27, 1998New England Journal of MedicineOpen Access

Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia

View Full Paper
Ask AI
Bookmark
Share

Authors

HCHélène CavéInsermJBJutte van der Werff ten BoschErasmus HospitalSSStefan SuciuEuropean Organisation for Research and Treatment of Cancer

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cavé et al. (1998) studied this question.

synapsesocial.com/papers/6a10ee3239dd87f6d0ee95b4https://doi.org/10.1056/nejm199808273390904
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients1991 · 204 citations
  2. 2Measurement of Residual Leukemia during Remission in Childhood Acute Lymphoblastic Leukemia1997 · 186 citations
  3. 3Detection of minimal residual disease in acute lymphoblastic leukemia by in vitro amplification of rearranged T-cell receptor delta chain sequences1989 · 190 citations
  4. 4Minimal Residual Disease in Childhood B-Lineage Lymphoblastic Leukemia1990 · 205 citations
  5. 5Gene rearrangement in B- and T-lymphoproliferative disease detected by the polymerase chain reaction [see comments]1991 · 389 citations